Oticon More vs RxEars Rxi

The Oticon More is a premium behind-the-ear prescription hearing aid that earned an A grade with a SoundScore of 4.6/5 in our lab testing, placing it in the top 22% of the 36 prescription hearing aids we've evaluated. Released in 2021, this device remains competitive and has received HearAdvisor's Expert's Choice Award in both 2023 and 2024. In our testing, the Oticon More demonstrated strong speech clarity performance. Speech in quiet scored 4.0/5, which is 0.73 points above the category average—a notable margin that reflects genuine audibility advantages in everyday conversations. Speech in noise measured 2.7/5, which is above the category average by 0.75 points, though only mixed in absolute terms, meaning challenging listening environments may still require effort. Own-voice comfort scored a solid 3.1/5 (+0.35 vs category average), and music streaming measured 3.0/5 (+0.36 vs category average), both performing above typical prescription aids. Feedback handling scored 3.5/5, which is solid in absolute terms, though below the category average of 4.71/5 by 1.21 points—something to discuss with your hearing care provider. At $4,598, this is a premium-priced device offering iPhone and Android streaming, hands-free calling, and your choice of rechargeable or disposable batteries. The Oticon More is well-suited for those prioritizing speech clarity who want a proven performer from an established manufacturer. Competitors in this price range include the newer Oticon Intent (4.85/5) and Oticon Real (4.75/5), which may be worth comparing during your fitting appointment.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.